30 participants
A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-13
- Start Date:
- 2021-12-01
- Completion:
- 2024-04-30
Conditions
- Donafenib
Interventions
- DRUG
- PROCEDURE
No Results Yet